Genpact Limited (G) Fair Value & Analysis
Technology · US · Market cap $5.3B
Fair value as of: Jul 17, 2026
From 26 valuation models · updated 23 days ago
Share price +16.9% over the past month.
A solid business, screening 76% undervalued on our models.
What matters now
- The rarer combination: high quality (70/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case ($43.81). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.
How to read this chart
60‑month range $27.50 – $54.13 · fair‑value band $43.81 – $76.59 · the $34.29 price screens below the $60.20 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.
Analysis
Genpact Limited (G) currently trades at $34.29, while our model-based Fair Value estimate is $60.20, implying the stock looks roughly 75.6% undervalued today. The Quality Score stands at 70/100 (solid quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Genpact Limited generated revenue of $5.2B at a net margin of 11.0%. Revenue grew 6.7% year over year. It earns a return on equity of 23.1%. Net debt stands at $911M. Fundamentals as of Jul 17, 2026
Our scenario range runs from $43.81 (bear case) to $76.59 (bull case); at $34.29, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 29% below its 52-week high and 19% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -25% fair-value upside, at 76%, G screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models ($71.57) versus Asset-Based ($10.08). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 68 · Market factors (momentum, volatility) 38
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Genpact Limited provides business process outsourcing and information technology services in India, the rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing.
Full company description
Genpact Limited provides business process outsourcing and information technology services in India, the rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers customer onboarding, customer service, collections, retail and commercial loan operations, payment operations, mortgage origination and servicing, compliance, wealth management, capital market operations support, financial crime and risk management, proprietary insurance policy suite, underwriting support, new business processing, policy administration, customer, claims management, catastrophe and exposure/risk modeling, actuarial services, end-to-end third-party administration for property and casualty claims, and technology services. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, digital commerce, customer experience, lifecycle management, regulatory operations, chemistry manufacturing control compliance, regulatory information management, claims processing and adjudication, claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers solutions for trust and safety, advertising sales support, customer and user experience, customer care support, supply chain management, direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It offers digital operations, data-tech-AI, advisory, agent technology; enterprise functional services, such as finance and accounting, human resources, sales and commercial operations, marketing, and global business solutions. The company has strategic alliance with Google Cloud. The company was founded in 1997 and is based in Hamilton, Bermuda.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Genpact Limited reported revenue of $5.1B in FY2025 versus $4.0B in FY2021, a compound +6.0%/yr. Reported net income was $552M in FY2025, compounding +10.6%/yr from FY2021.
Watch G: get an alert when its fair value changes →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- G Q2 Earnings Beat Estimates on ATS Growth, Outlook Raised
- Genpact Ltd (G) (Q2 2026) Earnings Call Highlights: Advanced Tech Surges 24% as Strategic Pivot ...
- Genpact (G) Reports Earnings Tomorrow: What To Expect
- Genpact signals at least 25% 2026 Advanced Technology Solutions growth as it targets over $1B in agentic TCV
Peer Group
Information Technology Services · 480 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Information Technology Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 46/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| International Business Machines Corporation IBM | $235.92 | $143.90 | -39% |
| Accenture plc ACNN | 2,460 MXN | 250.95 MXN | -90% |
| Infosys Limited INFY | ₹1,156 | ₹1,457 | +26% |
| HCL Technologies Limited HCLTECH | ₹1,204 | ₹1,230 | +2% |
| Wipro Limited WIPRO | ₹178.43 | ₹226.81 | +27% |
| Tech Mahindra Limited TECHM | ₹1,455 | ₹1,086 | -25% |
| Samsung SDS Co 018260 | 199,300 KRW | 196,390 KRW | -1% |
| Persistent Systems Limited PERSISTENT | ₹5,059 | ₹2,364 | -53% |
| Hyundai Autoever Corporation 307950 | 393,000 KRW | 133,088 KRW | -66% |
| Coforge Limited COFORGE | ₹1,541 | ₹702.84 | -54% |
Compare Genpact Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Genpact Limited (G) overvalued or undervalued?
What is the fair value of G?
What is the quality score of G?
What is the revenue of Genpact Limited (G)?
What is the net profit margin of G?
Does Genpact Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Genpact Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.